Nearly 15 million Californians on Medi-Cal, ~38% of the state
GLP-1s are necessary medical treatments, not a luxury
Everyone, regardless of income, deserves access to the treatments they need.
What’s at Stake
New restrictions have pulled coverage for GLP-1s
In 2023, Medi-Cal began covering GLP-1s, metabolic medications that reduce the risk of type 2 diabetes, cardiovascular disease, chronic kidney disease, obstructive sleep apnea, fatty liver disease, and heart failure. However, in 2026, Governor Newsom made the decision to cut coverage of these medications.